Cargando…

Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition

Trastuzumab, a HER2-targeted antibody, is widely used for targeted therapy of HER2-positive breast cancer (BC) patients; yet, not all of them respond to this treatment. We investigated here whether trastuzumab activity on the growth of HER2-overexpressing BT474 cells may interfere with human periphe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamashev, Dmitrii, Shaban, Nina, Suntsova, Maria, Raevskiy, Mikhail, Efimov, Victor, Moisseev, Aleksey, Sorokin, Maxim, Buzdin, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405390/ https://www.ncbi.nlm.nih.gov/pubmed/36009461 http://dx.doi.org/10.3390/biomedicines10081914

Ejemplares similares

Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways
por: Kamashev, Dmitri, et al.
Publicado: (2023)

Human blood serum can donor-specifically antagonize effects of EGFR-targeted drugs on squamous carcinoma cell growth
por: Kamashev, Dmitry, et al.
Publicado: (2021)

Better Agreement of Human Transcriptomic and Proteomic Cancer Expression Data at the Molecular Pathway Activation Level
por: Raevskiy, Mikhail, et al.
Publicado: (2022)

RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples
por: Sorokin, Maxim, et al.
Publicado: (2021)

Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification
por: Zakharova, Galina, et al.
Publicado: (2022)

Transcriptomic Portraits and Molecular Pathway Activation Features of Adult Spinal Intramedullary Astrocytomas
por: Konovalov, Nikolay, et al.
Publicado: (2022)

Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability
por: Sorokin, Maksim, et al.
Publicado: (2021)

Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles
por: Borisov, Nicolas, et al.
Publicado: (2021)

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma
por: Sorokin, Maxim, et al.
Publicado: (2021)

Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells
por: SEO, HYE-SOOK, et al.
Publicado: (2016)

Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells
por: Akbari, Azam, et al.
Publicado: (2020)

COVID-19–associated inhibition of energy accumulation pathways in human semen samples
por: Adamyan, Leila, et al.
Publicado: (2021)

Voltage-gated K(+) channels promote BT-474 breast cancer cell migration
por: Chow, Louis WC, et al.
Publicado: (2018)

Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells
por: Seo, Hye-Sook, et al.
Publicado: (2015)

Design and Characterization of Liposomal Methotrexate and Its Effect on BT-474 Breast Cancer Cell Line
por: Tavakoli Dastjerd, Niloufar, et al.
Publicado: (2021)

In Vitro Cytotoxicity of Trastuzumab (Tz) and Se-Trastuzumab (Se-Tz) against the Her/2 Breast Cancer Cell Lines JIMT-1 and BT-474
por: Bapat, Priyanka, et al.
Publicado: (2021)

OncoboxPD: human 51 672 molecular pathways database with tools for activity calculating and visualization
por: Zolotovskaia, Marianna A., et al.
Publicado: (2022)

Case of multifocal glioblastoma with four fusion transcripts of ALK, FGFR2, NTRK2, and NTRK3 genes stresses the need for tumor tissue multisampling for transcriptomic analysis
por: Samii, Amir, et al.
Publicado: (2021)

Protein O-glucosyltransferase 1 overexpression downregulates p16 in BT474 human breast cancer cells
por: JIN, GANG, et al.
Publicado: (2014)

Whole genome sequence analysis of BT-474 using complete Genomics’ standard and long fragment read technologies
por: Ciotlos, Serban, et al.
Publicado: (2016)

Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data
por: Sorokin, Maxim, et al.
Publicado: (2022)

Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data
por: Rabushko, Elizaveta, et al.
Publicado: (2022)

Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells
por: Pustovalova, Margarita, et al.
Publicado: (2023)

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line
por: Vasiliou, Stella K., et al.
Publicado: (2022)

The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol
por: López-Méndez, José A., et al.
Publicado: (2023)

Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling
por: Lebedev, Timofey, et al.
Publicado: (2022)

Mutation Enrichment and Transcriptomic Activation Signatures of 419 Molecular Pathways in Cancer
por: Zolotovskaia, Marianna A., et al.
Publicado: (2020)

Total Phenolic and Flavonoid Contents of Aqueous Extract of Stinging Nettle and In Vitro Antiproliferative Effect on Hela and BT-474 Cell Lines
por: Fattahi, Sadegh, et al.
Publicado: (2014)

Differences between human and chimpanzee genomes and their implications in gene expression, protein functions and biochemical properties of the two species
por: Suntsova, Maria V., et al.
Publicado: (2020)

RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case Report
por: Seryakov, Alexander, et al.
Publicado: (2021)

Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
por: Weingaertner, Inka Regine, et al.
Publicado: (2013)

Magnetic thermoablation stimuli alter BCL2 and FGF-R1 but not HSP70 expression profiles in BT474 breast tumors
por: Stapf, Marcus, et al.
Publicado: (2015)

ONC201-Induced Mitochondrial Dysfunction, Senescence-like Phenotype, and Sensitization of Cultured BT474 Human Breast Cancer Cells to TRAIL
por: Mishukov, Artem, et al.
Publicado: (2022)

RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer
por: Sorokin, Maxim, et al.
Publicado: (2020)

Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
por: Zolotovskaia, Marianna, et al.
Publicado: (2021)

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.
por: van Slooten, H. J., et al.
Publicado: (1995)

Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
por: Weingaertner, Inka Regine, et al.
Publicado: (2016)

Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
por: Weingaertner, Inka Regine, et al.
Publicado: (2015)

RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
por: Sorokin, Maxim, et al.
Publicado: (2020)

DNA repair pathway activation features in follicular and papillary thyroid tumors, interrogated using 95 experimental RNA sequencing profiles
por: Vladimirova, Uliana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5dojlrgg70pagif2g50isbvugt